Stebbing, Justin http://orcid.org/0000-0002-1117-6947
Baranau, Yauheni V.
Baryash, Valery
Manikhas, Alexey
Moiseyenko, Vladimir
Dzagnidze, Giorgi
Zhavrid, Edvard
Boliukh, Dmytro
Pikiel, Joanna
Eniu, Alexandru E. http://orcid.org/0000-0001-6666-5599
Li, Rubi K.
Tiangco, Beatrice
Lee, Sang Joon http://orcid.org/0000-0001-9897-2163
Kim, Sunghyun
Funding for this research was provided by:
Celltrion, Inc.
Article History
Received: 8 March 2021
Accepted: 20 April 2021
First Online: 20 June 2021
Declarations
:
: JS has served on scientific advisory boards for Alveo Technologies, Inc., BenevolentAI, Celltrion, Certis Oncology Solutions, Inc., Eli Lilly and Company, Greenmantle, Heat Biologics, Inc., Replete Pharmaceuticals Private Ltd, Vaccitech Ltd, and Zedsen Ltd; has consulted for Lansdowne Partners Ltd and Vitruvian Partners; sits on the Board of Directors for BB Biotech Healthcare Trust PLC; and is Editor-in-Chief of Oncogene, outside the submitted work. VM reports grants from Pfizer Inc. and Samsung Bioepis Co., Ltd, outside the submitted work. AEE reports grants from Celltrion, Inc. during the conduct of the study, and grants from AstraZeneca PLC, Pfizer Inc., and F. Hoffmann-La Roche AG outside the submitted work. SJL is employed by and has stock options with Celltrion, Inc. SK is employed by Celltrion, Inc. YVB, VB, AM, GD, EZ, DB, JP, RKL and BT have no competing interests to declare.
: The protocol was reviewed and approved by the relevant independent ethics committees for each center. All procedures performed were in line with the 1964 Helsinki Declaration and its later amendments, Good Clinical Practice guidelines, and all applicable regulatory requirements.
: All patients provided written informed consent.